BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35567784)

  • 1. Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis.
    Ng PLF; Lim YC; Evangelista LKM; Wong RCC; Chai P; Sia CH; Loi HY; Yeo TC; Lin W
    Ann Noninvasive Electrocardiol; 2022 Jul; 27(4):e12967. PubMed ID: 35567784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure.
    Löfbacka V; Suhr OB; Pilebro B; Wixner J; Sundström T; Lindmark K; Anan I; Lindqvist P
    Clin Physiol Funct Imaging; 2021 Sep; 41(5):408-416. PubMed ID: 34033209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality imaging approach to cardiac amyloidosis: part 2.
    Sennott J; Ananthasubramaniam K
    Heart Fail Rev; 2022 Sep; 27(5):1515-1530. PubMed ID: 34694574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
    Zhang KW; Zhang R; Deych E; Stockerl-Goldstein KE; Gorcsan J; Lenihan DJ
    Am Heart J; 2021 Feb; 232():137-145. PubMed ID: 33212046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic imaging of cardiac amyloidosis.
    Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
    Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
    Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
    Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis?
    Hartmann A; Frenkel J; Hopf R; Baum RP; Hör G; Schneider M; Kaltenbach M
    Int J Card Imaging; 1990; 5(4):227-31. PubMed ID: 2172406
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
    ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic features and rhythm disorders in cardiac amyloidosis.
    Martini N; Sinigiani G; De Michieli L; Mussinelli R; Perazzolo Marra M; Iliceto S; Zorzi A; Perlini S; Corrado D; Cipriani A
    Trends Cardiovasc Med; 2024 May; 34(4):257-264. PubMed ID: 36841466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac amyloidosis: combined use of two-dimensional echocardiography and electrocardiography in noninvasive screening before biopsy.
    Sivaram CA; Jugdutt BI; Amy RW; Basualdo CA; Haraphongse M; Shnitka TK
    Clin Cardiol; 1985 Oct; 8(10):511-8. PubMed ID: 4053429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Echocardiographic analysis in cardiac amyloidosis].
    Hurrel C; Deriaz-Chessex S; Waeber G; Jeanrenaud X; Périard D
    Praxis (Bern 1994); 2006 Jun; 95(24):977-81. PubMed ID: 16802507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiogram Criteria to Diagnose Cardiac Amyloidosis in Men With a Bundle Branch Block.
    Sharma S; Labib SB; Shah SP
    Am J Cardiol; 2021 May; 146():89-94. PubMed ID: 33529617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
    Gertz MA; Brown ML; Hauser MF; Kyle RA
    Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.
    Dubrey SW; Cha K; Skinner M; LaValley M; Falk RH
    Heart; 1997 Jul; 78(1):74-82. PubMed ID: 9290406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
    Bravo PE; Dorbala S
    Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation.
    Di Bella G; Minutoli F; Piaggi P; Casale M; Mazzeo A; Zito C; Oreto G; Baldari S; Vita G; Pingitore A; Khandheria BK; Carerj S
    Am J Cardiol; 2015 Oct; 116(7):1122-7. PubMed ID: 26253999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.